Blood test may predict rapid kidney decline in diabetes
NCT ID NCT04960514
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial tests whether a blood-based test called KidneyIntelX can help doctors better manage type 2 diabetes patients with early to moderate chronic kidney disease. The test estimates the risk of rapid kidney function decline over five years. Researchers will see if using this test leads to more patients hitting treatment targets, like blood pressure and blood sugar control, and receiving protective medications. The goal is to see if this tool improves clinical decisions and ultimately slows kidney damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- KidneyIntelX, a blood-based diagnostic test that predicts the risk of rapid kidney function decline
- What this could lead to
- If effective, this test could help doctors identify high-risk patients earlier and tailor treatments to slow kidney disease progression.
- What could go wrong
- The trial is large but focuses on whether the test changes doctor decisions, not on long-term patient outcomes. The test may not lead to meaningful improvements in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE STAGE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atrium Health Wake Forest Baptist - Family Medicine - Piedmont Plaza
Winston-Salem, North Carolina, 27104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could flag rapid kidney failure risk in diabetes
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Could your blood type predict kidney treatment success?
- One infusion, two targets: a uric-acid-lowering drug takes aim at heart and kidney disease in youth-onset diabetes
- Personalizing kidney treatment: can biomarkers predict who benefits from finerenone?